LINDANE Drug Patent Profile
✉ Email this page to a colleague
When do Lindane patents expire, and when can generic versions of Lindane launch?
Lindane is a drug marketed by Olta Pharms and Wockhardt Bio Ag and is included in four NDAs.
The generic ingredient in LINDANE is lindane. There are two drug master file entries for this compound. Additional details are available on the lindane profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LINDANE?
- What are the global sales for LINDANE?
- What is Average Wholesale Price for LINDANE?
Summary for LINDANE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 199 |
| Clinical Trials: | 1 |
| Drug Prices: | Drug price information for LINDANE |
| DailyMed Link: | LINDANE at DailyMed |
Recent Clinical Trials for LINDANE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Edward Via Virginia College of Osteopathic Medicine | N/A |
Medical Subject Heading (MeSH) Categories for LINDANE
Anatomical Therapeutic Chemical (ATC) Classes for LINDANE
US Patents and Regulatory Information for LINDANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Olta Pharms | LINDANE | lindane | LOTION;TOPICAL | 087313-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wockhardt Bio Ag | LINDANE | lindane | SHAMPOO;TOPICAL | 088191-001 | Sep 18, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wockhardt Bio Ag | LINDANE | lindane | LOTION;TOPICAL | 088190-001 | Aug 16, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Olta Pharms | LINDANE | lindane | SHAMPOO;TOPICAL | 087266-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
